9.5 to 11.5 in a week and a double in the past few months, it might need a rest at some point. Most stocks still have the laws of gravity in effect, but not always in biotech. For the first indication sales estimates are not $BB's so they need to show efficacy in Pnumonia before going to $BB+ market cap IMO. It's been a great ride and I am not selling any stock here and I recently upped my covered call prices to $12.5 in Sept and $15 in Dec. I don't think I will do that again. If I get called away, I will just have to pay the high taxes.
It just might come down today, and if it does, watch it explode higher next week. Right now there are just too many catalysts to hold TSRX down, as the market potential for Tedizolid is in the billions. Let's Ride!